Viewing nowCombinationSRBD Tablet
Ranitidine Hydrochloride 168mg · Tripotassium Bismuth Dicitrate 200mg +1 more
Tablet · Prescription medication · Combination
Samchundang Pharmaceutical Co., Ltd.

MFDS item code 201604940 · Approved 2016.08.12
Treatment of acid-related disorders (such as gastric ulcers and gastritis); prevention of Mendelson syndrome before anesthesia
This medication is used to treat gastrointestinal-related conditions such as gastric ulcers, gastritis, duodenal ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It can also be administered prior to anesthesia to prevent Mendelson syndrome, and it aids in the treatment of ulcers that may occur post-surgery. It is effective in managing gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). It is used to alleviate the symptoms of various gastrointestinal diseases and improve lesions.
Usually, take 1 tablet orally twice daily, in the morning and at bedtime, regardless of meals. Gastric and duodenal ulcers Take 1 tablet twice daily, or 2 tablets once daily at bedtime. A higher cure rate may be achieved, particularly in patients with duodenal ulcers, by taking 2 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) or for the prevention of gastric and duodenal ulcers during long-term NSAID treatment. NSAID-induced conditions usually heal within 4 weeks, and ulcers usually heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 1 tablet once daily at bedtime as maintenance therapy. Gastroesophageal reflux disease Take 1 tablet twice daily or 2 tablets once daily at bedtime for 8 weeks. In patients with severe gastroesophageal reflux disease, the dose may be increased to 2 tablets 4 times daily. Zollinger-Ellison syndrome Initiate treatment with 1 tablet 3 times daily as the initial dose, and increase the dose as needed. In severe cases, up to 6 g of ranitidine daily may be administered as directed by a physician. Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and give 1 tablet twice daily. Preanesthetic medication (prevention of Mendelson syndrome) Administer 1 tablet 2 hours before induction of anesthesia. It is also preferable to administer 1 tablet on the night before surgery.
This drug should not be used in patients receiving dialysis or those with kidney function problems. It should also be avoided in patients with a history of allergic reactions to this drug or its components. Patients with a history of acute porphyrias should be cautious as this drug may worsen symptoms. It is recommended not to administer the drug to patients who have undergone upper gastrointestinal tract surgery, pregnant women, or those with a possibility of pregnancy, as well as to premature infants or newborns. Patients on a diet that restricts potassium intake should also avoid using this drug. Patients with liver dysfunction or a history of drug allergies, the elderly, or those with a history of kidney dysfunction should use this drug carefully. Caution is especially needed for those taking NSAIDs simultaneously, and regular health checks are necessary. This drug may hide the symptoms of stomach cancer; therefore, patients with gastric ulcers or newly arisen dyspeptic symptoms over middle age should confirm malignancy before use. Patients with Helicobacter pylori infection with gastric or duodenal ulcers should also undergo bacterial eradication treatment. Caution is needed for severely ill patients in intensive care units, patients with hypophosphatemia, or patients who have difficulty swallowing. Rarely, serious allergic reactions or skin rashes, blood abnormalities, liver dysfunction, cardiac arrhythmias, gastrointestinal symptoms, and neurological abnormalities may occur during the administration of this drug, so consult a doctor immediately if abnormal symptoms arise. It is advised not to use this drug for long periods and to check for treatment effects; substitute with another medication if necessary. Elderly patients or those with chronic pulmonary diseases or diabetes may have an increased risk of pneumonia, so caution is warranted. Avoid driving or operating dangerous machinery if dizziness or drowsiness occurs. This drug may interact with other medications, so it is important to inform your doctor or pharmacist about any other drugs being taken. It is safer not to use this drug for pregnant or breastfeeding women. Safety and efficacy have not been established in children, so its use is not recommended. In case of overdose, appropriate treatment such as vomiting or gastric lavage is needed and may be removed by dialysis. This drug may reduce gastric acid secretion, promoting bacterial growth in the stomach; therefore, ophthalmic examinations may be necessary for long-term use.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air or moisture from entering, and it is safe to store at room temperature between 1°C and 30°C. Proper storage helps maintain the medication's effectiveness for a long period.
Light green rectangular film-coated tablet
30 tablets per bottle, 300 tablets per bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRanitidine Hydrochloride 168mg · Tripotassium Bismuth Dicitrate 200mg +1 more
Tablet · Prescription medication · Combination
Samchundang Pharmaceutical Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.